Cancer fertility preservation: a report from a Brazilian social program

Berton, Caroline Z; Brogliato, Caroline; Yoshida, Ivan Henrique; Vellez, Laura T; Suganuma, Claudia H; Cordts, Emerson Barchi; Conceição, Gabriel Seixas; Barbosa, Caio Parente

doi:10.5935/1518-0557.20190089

Cited by 2 publications

(2 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Results in non‐HIC countries, despite of improvements as reported above, remain definitely less favourable. This may be due in part, as suggested by Lee, to some ethnical specificities such as the frequency of different cytogenetic ALL subtypes 11 or constitutional genetic variability 75,76 . Other unfavourable factors include late presentation with high tumour burden, delayed diagnosis, denial and abandonment, malnutrition, poor supportive treatments and suboptimal care 23 .…”

Section: Discussion (A Biondi V Conter and P Hokland)mentioning

confidence: 99%

“…Counselling about preserving one's fertility should be offered to all patients. 11 Despite that, in the Brazilian Public Healthcare System, which is responsible for the treatment of the vast majority of patients, female fertility preservation is not widely available at the present time. Moreover, even within private services, this option is not easily accessible for nearly all patients.…”

Section: The Perspective From Brazil (Mlm Lee)mentioning

confidence: 99%

See 1 more Smart Citation

Precursor B‐cell acute lymphoblastic leukaemia—a global view

et al. 2021

View full text Add to dashboard Cite

As haematologists, we always seek to follow standardised guidelines for practice and apply the best treatment within our means for our patients with blood diseases. However, treatment can never follow an exact recipe. Opinions differ as to the best approach; sometimes more than one treatment approach results in identical outcomes, or treatments differ only by the manner in which they fail. Furthermore, the haematologist is faced with constraints relating to the local economic environment. Patients too are not the same the world over. Early presentation is commoner in the developed world, as is the patient's understanding of the disease process. This in turn has an impact on the way patients are managed, the rigorousness of patient adhesion to the treatment schedule and the outcome. Here we take a look at the precursor B-cell acute lymphoblastic leukaemia in an adolescent in a range of different settings from low-to high income countries with widely differing challenges for diagnosis, therpy and follow-up. For these reasons, given the same starting conditions, patients will be treated differently according to the institute and the country they are in. Experts from around the world have been tasked to describe their management plan and rationale for a specific disease presentation. Here they explore the management of precursor B-cell acute lymphoblastic leukaemia (pre-B ALL) in five different institutions worldwide with a focus on those with more or less strained economies. We end with a conclusion from an expert in the field comparing and contrasting these different management styles and considering their merits and limitations.

show abstract

Section: Discussion (A Biondi V Conter and P Hokland)mentioning

confidence: 99%

Section: The Perspective From Brazil (Mlm Lee)mentioning

confidence: 99%

Precursor B‐cell acute lymphoblastic leukaemia—a global view

et al. 2021

View full text Add to dashboard Cite

show abstract

A comprehensive review and update on human fertility cryopreservation methods and tools

et al. 2023

View full text Add to dashboard Cite

The broad conceptualization of fertility preservation and restoration has become already a major concern in the modern western world since a large number of individuals often face it in the everyday life. Driven by different health conditions and/or social reasons, a variety of patients currently rely on routinely and non-routinely applied assisted reproductive technologies, and mostly on the possibility to cryopreserve gametes and/or gonadal tissues for expanding their reproductive lifespan. This review embraces the data present in human-focused literature regarding the up-to-date methodologies and tools contemporarily applied in IVF laboratories' clinical setting of the oocyte, sperm, and embryo cryopreservation and explores the latest news and issues related to the optimization of methods used in ovarian and testicular tissue cryopreservation.

show abstract

Cancer fertility preservation: a report from a Brazilian social program

Cited by 2 publications

References 15 publications

Precursor B‐cell acute lymphoblastic leukaemia—a global view

Precursor B‐cell acute lymphoblastic leukaemia—a global view

A comprehensive review and update on human fertility cryopreservation methods and tools

Contact Info

Product

Resources

About